Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

KLRG1, Cadherins and their Interaction (35.29)

View through CrossRef
Abstract The killer cell lectin-like receptor G1 (KLRG1) is a unique inhibitory receptor expressed on a phenotypically mature subset of resting NK cells as well as effector memory CD8+ T cells. KLRG1 is a C-type lectin inhibitory receptor that contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) in its cytoplasmic domain. KLRG1 ligands have been recently identified and are members of the broadly expressed cadherin family, N-, R-, and E-cadherin. In this study, we attempt to elucidate the consequences of cadherin engagement by KLRG1 as well as KLRG1 engagement by cadherin. We found that E-cadherin engagement by KLRG1 influences the dynamics of cell adhesion. Along this line, we showed that E-cadherin and KLRG1 interaction regulates the signaling properties of E-cadherin. These data are supported by the fact that recombinant extracellular domain of N-cadherin blocks KLRG1 tetramer binding to cadherin expressing cells. In addition, we show that recombinant extracellular domain of N-cadherin functions to regulate KLRG1 signaling. We also demonstrated ex vivo that KLRG1 engagement by E-cadherin induces a significant inhibition of TCR signaling. Notably, upon analysis of E-cadherin mutants, we discovered that E-cadherin's cytoplasmic domain regulates its cell surface expression. Taken together, our data suggest that immune receptor interaction with cadherin may have an impact not only on immune cells such as NK cells but also on cells expressing cadherin such as epithelial cells. Supported by NIH grant AI 58181.
Title: KLRG1, Cadherins and their Interaction (35.29)
Description:
Abstract The killer cell lectin-like receptor G1 (KLRG1) is a unique inhibitory receptor expressed on a phenotypically mature subset of resting NK cells as well as effector memory CD8+ T cells.
KLRG1 is a C-type lectin inhibitory receptor that contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) in its cytoplasmic domain.
KLRG1 ligands have been recently identified and are members of the broadly expressed cadherin family, N-, R-, and E-cadherin.
In this study, we attempt to elucidate the consequences of cadherin engagement by KLRG1 as well as KLRG1 engagement by cadherin.
We found that E-cadherin engagement by KLRG1 influences the dynamics of cell adhesion.
Along this line, we showed that E-cadherin and KLRG1 interaction regulates the signaling properties of E-cadherin.
These data are supported by the fact that recombinant extracellular domain of N-cadherin blocks KLRG1 tetramer binding to cadherin expressing cells.
In addition, we show that recombinant extracellular domain of N-cadherin functions to regulate KLRG1 signaling.
We also demonstrated ex vivo that KLRG1 engagement by E-cadherin induces a significant inhibition of TCR signaling.
Notably, upon analysis of E-cadherin mutants, we discovered that E-cadherin's cytoplasmic domain regulates its cell surface expression.
Taken together, our data suggest that immune receptor interaction with cadherin may have an impact not only on immune cells such as NK cells but also on cells expressing cadherin such as epithelial cells.
Supported by NIH grant AI 58181.

Related Results

Association between senescence of T cells and disease activity in patients with systemic lupus erythematosus
Association between senescence of T cells and disease activity in patients with systemic lupus erythematosus
IntroductionSystemic lupus erythematosus (SLE) patients are predisposed to chronic immune activation, leading to accelerated immunosenescence. The aging of the immune system causes...
Assessment the Diversity of Circulating Natural Killer Cells Between Active Tuberculosis and Latent Tuberculosis Infection
Assessment the Diversity of Circulating Natural Killer Cells Between Active Tuberculosis and Latent Tuberculosis Infection
Abstract Background: Tuberculosis (TB) is a leading global public health problem, but the mechanisms underlying the immunopathology of TB progression are not well understoo...
Determining antitumor responses to variable cadherin expression
Determining antitumor responses to variable cadherin expression
Abstract Cancer immunotherapy has dramatically transformed the treatment of many cancers. Despite this, several limitations exist. For example, in some patients’ can...
The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment
The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment
Checkpoint blockade therapy (CBT) involving anti-PD1 antibodies represents the standard approach for cHL patients who do not respond to second-line therapy. Nonetheless, only 20% o...
The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment
The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment
AbstractCheckpoint blockade therapy (CBT) involving anti-PD1 antibodies represents the standard approach for cHL patients who do not respond to second-line therapy. Nonetheless, on...
DESMOSOMES IN ORAL DISEASES – A REVIEW
DESMOSOMES IN ORAL DISEASES – A REVIEW
Desmosomes are the adhesion proteins that function both as an adhesive complex and as a cell surface attachment site for keratin intermediate filaments of the cytoskeleton. Desmoso...
Measuring additive interaction using odds ratios
Measuring additive interaction using odds ratios
AbstractInteraction measured on the additive scale has been argued to be better correlated with biologic interaction than when measured on the multiplicative scale. Measures of int...

Back to Top